These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 26738290)

  • 1. [Expression of Chimeric Influenza Hemagglutinin Antigen (cH7/3) using the Baculovirus Expression System and Identification of its Biological Activities].
    Wang D; Qin K; Guo J; Zhao X; Lu S; Shu Y; Zhou J
    Bing Du Xue Bao; 2015 Sep; 31(5):524-9. PubMed ID: 26738290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of H1N1 influenza hemagglutinin protein expressed in a baculovirus system.
    Na HN; Kim KH; Song MK; Park HL; Lee EY; Shim SH; Park S; Nam JH
    Microbiol Immunol; 2013 Sep; 57(9):660-4. PubMed ID: 23822120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.
    Musthaq SK; Kumar SR; Szyporta M; Kwang J
    Antiviral Res; 2014 Sep; 109():42-53. PubMed ID: 24973759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes.
    Prabakaran M; Kumar SR; Raj KV; Wu X; He F; Zhou J; Kwang J
    Antiviral Res; 2014 Sep; 109():149-59. PubMed ID: 24997413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
    Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
    Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WSSV ie1 promoter is more efficient than CMV promoter to express H5 hemagglutinin from influenza virus in baculovirus as a chicken vaccine.
    He F; Ho Y; Yu L; Kwang J
    BMC Microbiol; 2008 Dec; 8():238. PubMed ID: 19116038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baculovirus vector as an avian influenza vaccine: hemagglutinin expression and presentation augment the vaccine immunogenicity.
    Chen CY; Lin SY; Cheng MC; Tsai CP; Hung CL; Lo KW; Hwang Y; Hu YC
    J Biotechnol; 2013 Mar; 164(1):143-50. PubMed ID: 23313887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.
    Li ZN; Mueller SN; Ye L; Bu Z; Yang C; Ahmed R; Steinhauer DA
    J Virol; 2005 Aug; 79(15):10003-12. PubMed ID: 16014960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of recombinant baculovirus co-expressing M1 and HA of influenza A virus].
    Xu PW; Guo JQ; Yao LH; Chen AJ; Liu XY; Zeng XY; Zhang ZQ
    Bing Du Xue Bao; 2012 May; 28(3):231-6. PubMed ID: 22764525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms.
    Chen CY; Liu HJ; Tsai CP; Chung CY; Shih YS; Chang PC; Chiu YT; Hu YC
    Vaccine; 2010 Nov; 28(48):7644-51. PubMed ID: 20883735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insect larvae biofactories as a platform for influenza vaccine production.
    Gomez-Casado E; Gomez-Sebastian S; Núñez MC; Lasa-Covarrubias R; Martínez-Pulgarín S; Escribano JM
    Protein Expr Purif; 2011 Sep; 79(1):35-43. PubMed ID: 21421054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines.
    Loureiro S; Ren J; Phapugrangkul P; Colaco CA; Bailey CR; Shelton H; Molesti E; Temperton NJ; Barclay WS; Jones IM
    J Virol; 2011 Mar; 85(6):3010-4. PubMed ID: 21191017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific subtyping of influenza A virus using a recombinant hemagglutinin protein expressed in baculovirus.
    Shahsavandi S; Salmanian AH; Ghorashi SA; Masoudi S; Fotouhi F; Ebrahimi MM
    Mol Biol Rep; 2011 Jun; 38(5):3293-8. PubMed ID: 21110118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse micelle-encapsulated recombinant baculovirus as an oral vaccine against H5N1 infection in mice.
    Prabakaran M; Madhan S; Prabhu N; Geng GY; New R; Kwang J
    Antiviral Res; 2010 May; 86(2):180-7. PubMed ID: 20153776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
    Treanor JJ; Schiff GM; Couch RB; Cate TR; Brady RC; Hay CM; Wolff M; She D; Cox MM
    J Infect Dis; 2006 May; 193(9):1223-8. PubMed ID: 16586358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine.
    Wu Q; Xiao S; Fan H; Li Y; Xu J; Li Z; Lu W; Su X; Zou W; Jin M; Chen H; Fang L
    Antiviral Res; 2011 Dec; 92(3):493-6. PubMed ID: 22020305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment of a lentivirus-mediated rapid eukaryotic expression system of novel avian influenza H7N9 virus hemagglutinin gene].
    Zhang L; Peng H; Zhou M; Yu H; Zeng X; Qi X; Cui L; Jiao Y; Shi Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):630-4. PubMed ID: 24909287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza.
    Tang XC; Lu HR; Ross TM
    Vaccine; 2010 Oct; 28(42):6821-31. PubMed ID: 20727393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The large-scale production of an artificial influenza virus-like particle vaccine in silkworm pupae.
    Nerome K; Sugita S; Kuroda K; Hirose T; Matsuda S; Majima K; Kawasaki K; Shibata T; Poetri ON; Soejoedono RD; Mayasari NL; Agungpriyono S; Nerome R
    Vaccine; 2015 Jan; 33(1):117-25. PubMed ID: 25448101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.